	Comparing [18F]-PSMA-1007, [18F]-choline positron emission tomography, computerized tomography and bone scintigraphy in prostate cancer recurrence. Medicina (B Aires) Bergero MA, Modina P, Arceluz M, Rios L, Costa L, David C, Faccio F. PMID: 41313098 [PubMed - indexed for MEDLINE]
	A plain language summary of the EORTC 1333/PEACE-3 study of enzalutamide alone vs enzalutamide plus radium-223 in patients with metastatic castrationresistant prostate cancer (mCRPC) and bone metastases. Future Oncol Tombal B, Saad F, Gallardo E, Soares A, Loriot Y, McDermott R, Briers E, Lagström M, Coens C, Poncet C, Fournier B, Gillessen S. PMID: 41313045 [PubMed - as supplied by publisher]
	EXPRESS: HCAR2 inhibits prostate cancer invasion and metastasis by regulating cAMP signaling pathway. J Investig Med Li Y, Chen H, Huang R. PMID: 41312963 [PubMed - as supplied by publisher]
	Association of IL-1Î² Gene Polymorphism with Prostate Cancer Severity, Prostate Volume, and PSA Levels: A Case-Control Study. Asian Pac J Cancer Prev Ismael AA, Hussein AM, Saber AA. PMID: 41312941 [PubMed - indexed for MEDLINE]
	Nonâ€‘coding RNAs in epithelialâ€‘mesenchymal transition of renal cell carcinoma (Review). Mol Med Rep Liu Z, Zhou H, Shen J, Qi Y, Gong X, Zhang C. PMID: 41312723 [PubMed - indexed for MEDLINE]
	LLM-BCgrading: Large language model-based Chinese medical long text classification for bladder cancer grade prediction. Digit Health Pan X, Wen L, Li Y, Zhang Y, Lu M. PMID: 41312143 [PubMed]
	Predictive Value of PSA Bounce Phenomenon after Stereotactic Body Radiation Therapy in a Large Population of Prostate Cancer Patients Treated By 1.5â€‰T MR Guided Adaptive Technique. Prostate Romei A, Orsatti C, Allegra AG, Nicosia L, Pastorello E, Ricchetti F, Giaj-Levra N, De-Colle C, Rigo M, Ruggieri R, Alongi F. PMID: 41311355 [PubMed - as supplied by publisher]
	Integrative multi-omics and single-cell transcriptomics reveal ARHGEF12 driving chemoresistance in bladder cancer. Hereditas Zhu K, Zhang Z, Li T, Sun Y, Zhu J, Wu L, Zhang X, Tong H, Qin Z, Wang A, He W. PMID: 41310897 [PubMed - indexed for MEDLINE]
	Micro-ultrasound for prostate cancer. Nat Rev Urol Guer M, Brisbane WG, Cash H, Ghai S, Klotz L, Wilson PFR, Kinnaird A. PMID: 41310306 [PubMed - as supplied by publisher]
	Is radiofrequency ablation of renal cancer metastases a suitable alternative to surgical metastectomy: A systematic review. Ir J Med Sci McNicholas DP, Dexter E, Hampson A, Evans J, Venugopal S. PMID: 41310301 [PubMed - as supplied by publisher]
	Personalized intensification of treatment for hormone-sensitive prostate cancer. Nat Rev Clin Oncol Cilento MA, Butler LM, Emmett L, Sweeney CJ. PMID: 41310272 [PubMed - as supplied by publisher]
	A clinically validated AI framework for kidney cancer detection and characterization. Commun Med (Lond) Petryshak B, Iljin M, Denissova A, Ariva J, Häide T, Lasn V, Reim M, Ivaniv I, Lillsaar T, Vilt H, Leht A, Karask A, Kiudma G, Käpp R, Salumaa P, Ilves P, Fishman D. PMID: 41310187 [PubMed - as supplied by publisher]
	Immunological factors underlying radiation-induced toxicity in prostate cancer patients: a systematic review. Discov Oncol Mose L, Aboelroos H, Zabini A, Fernandez-Palomo C, Zilli T, Dal Pra A, Mohamad O, Aebersold DM, Trappetti V, Shelan M. PMID: 41310062 [PubMed - as supplied by publisher]
	Metabolite-mediated mechanisms linking the urinary microbiome to bladder cancer. J Microbiol Tr, Lee HY, Choi HW. PMID: 41309232 [PubMed - indexed for MEDLINE]
	Authors' reply to: comment on 'Feasibility of randomisation to radical prostatectomy or standard care in patients with metastatic prostate cancer'. BJU Int Van den Eynde L, Ost P, Lumen N. PMID: 41309109 [PubMed - as supplied by publisher]
	Comment on 'Feasibility of randomisation to radical prostatectomy or standard care in patients with metastatic prostate cancer'. BJU Int Zhao K, Zhou Z, Dong Z. PMID: 41309069 [PubMed - as supplied by publisher]
	The role of 3D preclinical models in the Era of precision medicine: A bladder cancer perspective. Gene Frascolla C, Matroianni R, Simone G, Blandino G. PMID: 41308954 [PubMed - as supplied by publisher]
	Lysine demethylase 5D promotes CHEK1 inhibitor sensitivity through p38-mediated cyclooxygenase-2 expression in castration-resistant prostate cancer cells. J Pharmacol Exp Ther Zheng W, Li S, West RE 3rd, Donahue ER, Nolin TD, Li S, Wang QJ. PMID: 41308413 [PubMed - as supplied by publisher]
	Multimodal Fusion of mpMRI Radiomics, Clinical Features, and Hematological Biomarkers Enhances Machine Learning-Based Prediction of Biochemical Recurrence in Prostate Cancer Patients. Chem Biol Drug Des Zhu Y, Yang Z, Liu Z, Xu S, Wang X, Zhu X, Qian L. PMID: 41307988 [PubMed - indexed for MEDLINE]
	Impact of androgen deprivation therapy and androgen receptor pathway inhibitors on cardiac structure and function evaluated by echocardiography in males with prostate cancer: a systematic review and meta-analysis. Int Urol Nephrol Kemp BR, Durukan E, Skaarup KG, Østergren PB, Sønksen J, Fode M. PMID: 41307789 [PubMed - as supplied by publisher]

Articles 1 - 20 / 174284

Page 1 of 8715



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy